Synthesis, characterization and anticancer activity of certain 3-{4-(5-mercapto-1,3,4-oxadiazole-2-yl)phenylimino}indolin-2-one derivatives

Saudi Pharmaceutical Journal

Volumn 19, Issue 3, 2011, Pages 153-158

  Gudipati, Rajyalakshmi ^a   Anreddy, Rama Narsimha Reddy ^a   Manda, Sarangapani ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

1,3,4 Oxadiazole; Anticancer activity; Indole; Isatin; MTT; Schiff bases

Indexed keywords

3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO] 5 BROMO INDOLIN 2 ONE; 3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO] 5 CARBOXYLIC ACID INDOLIN 2 ONE; 3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO] 5 FLUORO INDOLIN 2 ONE; 3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO] 5 METHYL INDOLIN 2 ONE; 3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO] 5 NITRO INDOLIN 2 ONE; 3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO] 7 CARBOXYLIC ACID INDOLIN 2 ONE; 3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO] 7 CHLORO INDOLIN 2 ONE; 3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO]INDOLIN 2 ONE; 3 [4 (5 MERCAPTO 1,3,4 OXADIAZOLE 2 YL)PHENYLIMINO]INDOLIN 2 ONE DERIVATIVE; ANTINEOPLASTIC AGENT; CISPLATIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50;

EID: 79957950077     PISSN: 13190164     EISSN: 13190164     Source Type: Journal    
DOI: 10.1016/j.jsps.2011.03.002     Document Type: Article

References (25)

1. Aboraia A., Rahman H.M.A., Mahfuz N., Mohmoud A., Gendy E.L. Novel 5-(2-hydroxyphenyl)-3-substituted-2, 3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents. Bioorg. Med. Chem. 2006, 14:1236-1246.
2. Aydemir N., Bilaloglu R. Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. Mutat. Res. 2003, 537:43-51.
3. Bahl, A.A., 2004. Textbook of Organic Chemistry, 5th ed., S Chand and Company Ltd., New Delhi, p. 364.
4. Bhandari S., Bothara K., Raut M., Patil A., Sarkate A., Mokale V. Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives. Bioorg. Med. Chem. 2008, 16:1822-1831.
5. Cane A., Tournaire M.C., Barritault D., Crumeyrolle-Arias M. The Endogenous Oxindoles 5-Hydroxyoxindole and Isatin are Antiproliferative and Proapoptotic. Biochem. Biophys. Res. Commun. 2000, 276:379-384.
6. Debra C.Q., Kathy A.K., Kern E.R. In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiviral Res. 2006, 71:24-30.
7. Gursoy A., Karal N. Synthesis and primary cytotoxicity evaluation of 3-[[(3-phenyl-4(3H)-quinazolinone-2-yl)mercaptoacetyl]hydrazono]-1H-2-indolinones. Eur. J. Med. Chem. 2003, 38:633-643.
8. Hari H.P., Umashankar D., Wilson J.Q., Masami K., Hiroshi S., Jonathan R.D. Cytotoxic 3, 5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells. Eur. J. Med. Chem. 2008, 43:1-7.
9. Henry, G., Blatt, A.H., 1964. Organic synthesis collective, vol. I, 2nd ed. John Wiley and Sons, New York, pp. 327-334.
10. Karal N., Gursoy A., Kandemirli F., Shvets N., Kaynak F.B., Ozbey S., Kovalishyne V., Dimoglo A. Synthesis and structure-antituberculosis activity relationship of 1H-indole-2, 3-dione derivatives. Bioorg. Med. Chem. 2007, 15:5888-5904.
11. Khanum S.A., Shashikanth S., Umesh S., Kavitha R. Synthesis and antimicrobial study of novel heterocyclic compounds from hydroxybenzophenones. Eur. J. Med. Chem. 2005, 40:1156-1162.
12. Kucukguzel S.G., Kucukguzel I.K., Tatar E., Rollas S., Sahin F., Gulluce M., Clercq E.D., Kabasakal L. Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents. Eur. J. Med. Chem. 2007, 42:893-901.
13. Ladduwahetty T., Baker R., Cascieri M.A., Chamber J.M., Haworth K., Keown L.E., MacIntyre E., Metzger J.M., Owen S., Ryeroft W., Sadowski S., Seward E., Shepheard S.L., Swain C.L., Tattersall F.D., Watt A.P., Willianmson D.W., Hargreaves R.J. N-Heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists. J. Med. Chem. 1996, 39:2907-2913.
14. Lee D., Long S.A., Murray J.H., Adams J.L., Nuttall M.E., Nadeau D.P., Kikly K., Winkler J.D., Sung C.M., Ryan M.D., Levy M.A., Keller P.M., DeWolf W.E. Potent and selective nonpeptide inhibitors of caspases 3 and 7. J. Med. Chem. 2001, 44:2015-2020.
15. Leong C.O., Gaskell M., Martin E.A., Heydon R.T., Farmer P.B., Bibby M.C., Cooper P.A., Double J.A., Bradshaw T.D., Stevens M.F. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo. Br. J. Cancer 2003, 88:470-477.
16. Mamolo M.G., Zampieri D., Voi L., Fermeglia M., Ferrone M., Pricl S., Scialinoc G., Banfi E. Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations. Bioorg. Med. Chem. 2005, 13:3797-3808.
17. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 1991, 83:757-766.
18. Nargund L.V.G., Reddy G.R.N., Hariprasad V. Anti-inflammatory activity of substituted 1,3,4-oxadiazoles. J. Pharm. Sci. 1994, 83:246-248.
19. Osbild S., Brault L., Battaglia E., Bagrel D. Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells. Anticancer Res. 2006, 26:3595-3600.
20. Pandeya S.N., Sriram D., Nath G., Clercq E.D. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one. Pharm. Acta Helv. 1999, 74:11-17.
21. Pandeya S.N., Sriram D., Nath G., Clercq E.D. Synthesis and antimicrobial activity of Schiff and Mannich bases of isatin and its derivatives with pyrimidine. Il Farmaco 1999, 54:624-628.
22. Skehan P., Storeng R., Scudiero D., Monks A., McMohan J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82:1107-1112.
23. Sridhar S.K., Ramesh A. Synthesis and pharmacological activities of hydrazones, Schiff and Mannich bases of isatin derivatives. Biol. Pharm. Bull. 2001, 24(10):1149-1152.
24. Varma R.S., Chauhan S. Synthesis of substituted 2-phenylbenzothiazoles and 5(6)-nitro-1,3-disubsituted-benzimidazoline-2-thiones as CNS active agents. Ind. J. Chem. 1988, 27B:438-442.
25. Verma M., Pandeya S.N., Singh K., Stable J.P. Anticonvulsant activity of Schiff bases of isatin derivatives. Acta Pharm. 2004, 54:49-56.